185 related articles for article (PubMed ID: 14618675)
21. Presynaptic GABA(B) receptor modulation of glutamate exocytosis from rat cerebrocortical nerve terminals: receptor decoupling by protein kinase C.
Perkinton MS; Sihra TS
J Neurochem; 1998 Apr; 70(4):1513-22. PubMed ID: 9523568
[TBL] [Abstract][Full Text] [Related]
22. Tanshinone IIA, a constituent of Danshen, inhibits the release of glutamate in rat cerebrocortical nerve terminals.
Lin TY; Lu CW; Huang SK; Wang SJ
J Ethnopharmacol; 2013 May; 147(2):488-96. PubMed ID: 23542145
[TBL] [Abstract][Full Text] [Related]
23. An investigation into the effect of the type IV phosphodiesterase inhibitor rolipram in the modulation of glutamate release from rat prefrontocortical nerve terminals.
Wang SJ
Synapse; 2006 Jan; 59(1):41-50. PubMed ID: 16247764
[TBL] [Abstract][Full Text] [Related]
24. HTDP-2, a new synthetic compound, inhibits glutamate release through reduction of voltage-dependent Ca²⁺ influx in rat cerebral cortex nerve terminals.
Lin TY; Lu CW; Huang SK; Chou SS; Kuo YC; Chou SH; Tzeng WF; Leu CY; Huang RF; Liew YF; Wang SJ
Pharmacology; 2011; 88(1-2):26-32. PubMed ID: 21720189
[TBL] [Abstract][Full Text] [Related]
25. Echinacoside Inhibits Glutamate Release by Suppressing Voltage-Dependent Ca(2+) Entry and Protein Kinase C in Rat Cerebrocortical Nerve Terminals.
Lu CW; Lin TY; Huang SK; Wang SJ
Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27347934
[TBL] [Abstract][Full Text] [Related]
26. Noncompetitive metabotropic glutamate5 receptor antagonist (E)-2-methyl-6-styryl-pyridine (SIB1893) depresses glutamate release through inhibition of voltage-dependent Ca2+ entry in rat cerebrocortical nerve terminals (synaptosomes).
Wang SJ; Sihra TS
J Pharmacol Exp Ther; 2004 Jun; 309(3):951-8. PubMed ID: 14982967
[TBL] [Abstract][Full Text] [Related]
27. Inhibitory effect of glutamate release from rat cerebrocortical nerve terminals by resveratrol.
Chang Y; Wang SJ
Neurochem Int; 2009 Feb; 54(2):135-41. PubMed ID: 19059293
[TBL] [Abstract][Full Text] [Related]
28. (-)-Epigallocatechin gallate, the most active polyphenolic catechin in green tea, presynaptically facilitates Ca2+-dependent glutamate release via activation of protein kinase C in rat cerebral cortex.
Chou CW; Huang WJ; Tien LT; Wang SJ
Synapse; 2007 Nov; 61(11):889-902. PubMed ID: 17663453
[TBL] [Abstract][Full Text] [Related]
29. Rosmarinic Acid, a Bioactive Phenolic Compound, Inhibits Glutamate Release from Rat Cerebrocortical Synaptosomes through GABA
Wang CC; Hsieh PW; Kuo JR; Wang SJ
Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356653
[TBL] [Abstract][Full Text] [Related]
30. Cannabinoid CB1 receptor-mediated inhibition of glutamate release from rat hippocampal synaptosomes.
Wang SJ
Eur J Pharmacol; 2003 May; 469(1-3):47-55. PubMed ID: 12782184
[TBL] [Abstract][Full Text] [Related]
31. Potential antidepressant LY 367265 presynaptically inhibits the release of glutamate in rat cerebral cortex.
Wang SJ
Synapse; 2005 Mar; 55(3):156-63. PubMed ID: 15602751
[TBL] [Abstract][Full Text] [Related]
32. Cyclooxygenase 2 inhibitor celecoxib inhibits glutamate release by attenuating the PGE2/EP2 pathway in rat cerebral cortex endings.
Lin TY; Lu CW; Wang CC; Huang SK; Wang SJ
J Pharmacol Exp Ther; 2014 Oct; 351(1):134-45. PubMed ID: 25047516
[TBL] [Abstract][Full Text] [Related]
33. Presynaptic kappa-opioid and muscarinic receptors inhibit the calcium-dependent component of evoked glutamate release from striatal synaptosomes.
Rawls SM; McGinty JF; Terrian DM
J Neurochem; 1999 Sep; 73(3):1058-65. PubMed ID: 10461895
[TBL] [Abstract][Full Text] [Related]
34. Coenzyme Q10 inhibits the release of glutamate in rat cerebrocortical nerve terminals by suppression of voltage-dependent calcium influx and mitogen-activated protein kinase signaling pathway.
Chang Y; Huang SK; Wang SJ
J Agric Food Chem; 2012 Dec; 60(48):11909-18. PubMed ID: 23167655
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of glutamate release by cilnidipine in rat cerebrocortical nerve terminals (synaptosomes).
Lu CW; Lin TY; Huang SK; Wang SJ
Neuroreport; 2017 Jun; 28(9):527-532. PubMed ID: 28498149
[TBL] [Abstract][Full Text] [Related]
36. Presynaptic mechanisms underlying the alpha-lipoic acid facilitation of glutamate exocytosis in rat cerebral cortex nerve terminals.
Wang SJ; Chen HH
Neurochem Int; 2007 Jan; 50(1):51-60. PubMed ID: 16949179
[TBL] [Abstract][Full Text] [Related]
37. WAY208466 inhibits glutamate release at hippocampal nerve terminals.
Wang HY; Lu CW; Lin TY; Kuo JR; Wang SJ
Eur J Pharmacol; 2016 Jun; 781():117-27. PubMed ID: 27068148
[TBL] [Abstract][Full Text] [Related]
38. Inhibitory effect of glutamate release from rat cerebrocortical nerve terminals by α2 adrenoceptor agonist dexmedetomidine.
Chiu KM; Lin TY; Lu CW; Wang SJ
Eur J Pharmacol; 2011 Nov; 670(1):137-47. PubMed ID: 21914443
[TBL] [Abstract][Full Text] [Related]
39. Partial compensation for N-type Ca(2+) channel loss by P/Q-type Ca(2+) channels underlines the differential release properties supported by these channels at cerebrocortical nerve terminals.
Ladera C; Martín R; Bartolomé-Martín D; Torres M; Sánchez-Prieto J
Eur J Neurosci; 2009 Mar; 29(6):1131-40. PubMed ID: 19302149
[TBL] [Abstract][Full Text] [Related]
40. Plantainoside D Reduces Depolarization-Evoked Glutamate Release from Rat Cerebral Cortical Synaptosomes.
Chiu KM; Lee MY; Lu CW; Lin TY; Wang SJ
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770979
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
